Behçet's disease

Seminars in Ophthalmology

Volumn 20, Issue 3, 2005, Pages 199-206

  Bonfioli, Adriana A ^a   Orefice, Fernando ^b,c  

^a University of Pittsburgh School of Medicine   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Hospital Sao Geraldo   (Brazil)

Author keywords

Beh et; Diagnosis; Review; Therapy; Uveitis

Indexed keywords

ALPHA2A INTERFERON; ASPARTATE AMINOTRANSFERASE; AZASAN; AZATHIOPRINE; BILIRUBIN; CHLORAMBUCIL; COLCHICINE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; LACTATE DEHYDROGENASE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; THALIDOMIDE;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACNE; ACUTE GRANULOCYTIC LEUKEMIA; ALOPECIA; AMENORRHEA; AMNESIA; ANEMIA; ANOREXIA; ANOSMIA; ANXIETY DISORDER; APHTHOUS STOMATITIS; APHTHOUS ULCER; ARTHRALGIA; ARTHROPATHY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACKACHE; BEHCET DISEASE; BONE MARROW SUPPRESSION; BRADYCARDIA; BRONCHOSPASM; CHILL; CHINA; CLINICAL FEATURE; CONFUSION; CONSTIPATION; COUGHING; CREATININE BLOOD LEVEL; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DIZZINESS; DRY SKIN; DYSPEPSIA; DYSPNEA; EDEMA; EYE DISEASE; FATIGUE; FEVER; FLU LIKE SYNDROME; GASTRITIS; GENDER; GENITAL ULCER; GINGIVA BLEEDING; GINGIVA HYPERPLASIA; GINGIVITIS; GOITER; GYNECOLOGIC DISEASE; GYNECOMASTIA; HEADACHE; HEART ARRHYTHMIA; HEART FAILURE; HEMORRHAGIC CYSTITIS; HIRSUTISM; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPERTRICHOSIS; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; HYPOGLYCEMIA; HYPOPYON; IMMUNOSUPPRESSIVE TREATMENT; IMPOTENCE; INSOMNIA; IRAN; IRIDOCYCLITIS; IRRITABILITY; ISRAEL; ITALY; JAPAN; JAUNDICE; KIDNEY DISEASE; KOREA; LACTATE DEHYDROGENASE BLOOD LEVEL; LEG CRAMP; LETHARGY; LEUKOPENIA; LIVER TOXICITY; LIVER VENOOCCLUSIVE DISEASE; LYMPHOMA; MALAISE; MENSTRUATION DISORDER; MENTAL DEFICIENCY; MENTAL DISEASE; MIGRAINE; MOUTH ULCER; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; MYALGIA; NAUSEA; NERVOUSNESS; NEUROLOGIC DISEASE; PANCREATITIS; PANCYTOPENIA; PARESTHESIA; PERIPHERAL NEUROPATHY; PHARYNGITIS; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; PRURITUS; RASH; RETINA ARTERY OCCLUSION; RETINA EXUDATE; RETINA HEMORRHAGE; RETINA MACULA EDEMA; RETINA VASCULITIS; RETINA VEIN OCCLUSION; RETINOPATHY; REVIEW; RIGOR; SAUDI ARABIA; SEIZURE; SINUSITIS; SKIN DISEASE; SUICIDAL BEHAVIOR; TASTE DISORDER; THORAX PAIN; THROMBOCYTOPENIA; THROMBOSIS; TREMOR; TURKEY (REPUBLIC); URINARY TRACT INFECTION; URTICARIA; VASCULAR DISEASE; VERTIGO; VOMITING; XEROSTOMIA;

BEHCET SYNDROME; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 27144466710     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530500231953     Document Type: Review

References (34)

1. Behçet H. Über rezidiverende aphtose, durch ein virus verursachte geschwüre am mund, am auge und an den genitalien. Dermatol Wochenschr 1937; 105:1152-1157.
2. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999; 341:1284.
3. Smith EL, Schur PH. Clinical manifestations and diagnosis of Behcet's disease. www.uptodateonline.com. 2005 UpToDate®
4. Okada AA, Rao NA, Usui M. Behçet's disease. In Yanoff M, Duker JS: Ophthalmology, 2nd ed. 2004, Mosby Inc.
5. Abreu MT, Bonfioli AA, Orefice F. Doenca de Behcet. In Oréfice, F. Uveítes - Clínica e Cirúrgica. First Ed. Rio de Janeiro: Ed. Cultura Médica, 2000; 843-859.
6. Barra C, Belfort Jr. R, Abreu MT, Kim MK, Martins MC, Petrilli AMN. Behcet's disease in Brazil: A review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol 1991; 35:339-346.
7. Kurokawa MS, Suzuki N. Behçet's disease. Clin Exp Med 2004; 3:10-20.
8. Atmaca, LS, Batioglu, F. The efficacy of cydosporin-A in the treatment of Behcet's disease. Ophthalmic Surg 1994; 25:321.
9. Ozyazgan, Y, Yurdakul, S, Yazici, H, et al. Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: A single masked trial. Br J Ophthalmol 1992; 76:241.
10. Whitcup, SM, Salvo, EC, Nussenblatt, RB. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet's disease. Am J Ophthalmol 1994; 118:39.
11. Sajjadi, H, Soheilian, M, Ahmadieh, H, et al. Low dose cyclosporin-A therapy in Behcet's disease. J Ocul Pharmacol 1994; 10:553.
12. Sakane, T, Tareno, M. Novel approaches to Behcet's disease. Expert Opin Investig Drugs 2000; 9:1993.
13. Yazici, H, Pazarli, H, Barnes, CG, et al. A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 1990; 322:281.
14. Hamuryudan, H, Ozyazgan, Y, Hizli, N et al. Azathioprine in Behcet's syndrome. Effects on long-term prognosis. Arthritis Rheum 1997; 40:769.
15. Abdalla, MI, el-D Bahoat, N. Long-lasting remission of Behcet's disease after chlorambucil therapy. Br J Ophthalmol 1973; 57:706.
16. O'Duffy, JD, Robertson, DM, Goldstein, NP. Chlorambucil in the treatment of uveitis and meningoencephalitis of Behcet's disease. Am J Med 1984; 76:75.
17. Hamza, M, Meddeb, S, Mili, I, Ouertani, A. Bolus of cyclophosphamide and methylprednisolone in uveitis in Behcet's disease. Preliminary results with the use of new criteria of evaluation. Ann Med Interne (Paris) 1992; 143:438.
18. Pivetti-Pezzi, P, Accorinti, M, Pirraglia, et al. Interferon alpha for ocular Behcet's disease. Acta Ophthalmol Scand 1997; 75:720.
19. Mochizuki, M. Immunotherapy for Behcet's disease. Int Rev Immunol 1997; 14:49.
20. Nichols, JC, Ince, A, Akduman, L, Mann, ES. Interferon-alpha 2a treatment of neuro-Behcet disease. J Neuroophthalmol 2001; 21:109.
21. Zouboulis, CC, Orfanos, CE. Treatment of Adamantiades-Behcet disease with systemic interferon alfa. Arch Dermatol 1998; 134:1010.
22. Hamuryudan, V, Moral, F, Yurdakul, S, et al. Systemic interferon alpha-2b treatment in Behcet's syndrome. J Rheumatol 1994; 21:1098.
23. Alpsoy, E, Durusoy, C, Yilmaz, E, et al. Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study. Arch Dermatol 2002; 138:467.
24. Kotter, I, Zierhut, M, Eckstein, AK, et al. Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 2003; 87:423.
25. Alpsoy, E, Yilmaz, E, Basaran, E. Interferon therapy for Behcet's disease. J Am Acad Dermatol 1994; 31:617.
26. O'Duffy, JD, Calamia, K, Cohen, S, et al. Interferon-alpha treatment of Behcet's disease. J Rheumatol 1998; 25:1938.
27. Kotter, I, Gunaydin, I, Zierhut, M, Stubiger, N. The use of interferon alpha in Behcet disease: review of the literature. Semin Arthritis Rheum 2004; 33:320.
28. Kotter, I, Vonthein, R, Zierhut, M, et al. Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behcet disease: results of an open 4-center trial. Semin Arthritis Rheum 2004; 33:311.
29. Kotter, I, Zierhut, M, Eckstein, AK, et al. Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 2003; 87:423.
30. Zouboulis, CC, Orfanos, CE. Treatment of Adamantiades-Behcet disease with systemic interferon alfa. Arch Dermatol 1998; 134:1010.
31. Gardner-Medwin, JM, Smith, NJ, Powell, RJ. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease: Use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis 1994; 53:828.
32. Jorizzo, JL, White, WL, Wise, CM, et al. Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: Cutaneous polyarteritis nodosa and Behcet's disease. J Am Acad Dermatol 1991; 24:973.
33. Sfikakis, PP, Theodossiadis, PG, Katsiari, CG, et al. Effect of infliximab on sight-threatening panuveitis in Behcet's disease. Lancet 2001; 358:295.
34. Yasui, K, Ohta, K, Kobayashi, M, et al. Successful treatment of Behcet disease with pentoxifylline. Ann Intern Med 1996; 124:891.